Emmanuel S Antonarakis (George Sgouros, Emmanuel Antonarakis)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 89

Top Venues

The Prostate

Clinical cancer research : an official journal of the American Association for Cancer Research

Prostate cancer and prostatic diseases

JCO precision oncology

Johns Hopkins Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins Medicine

United States

Professor :: Oncology and Urology

Publications

Maha H A Hussain, Masha Kocherginsky, Archana M Agarwal, Nabil Adra, Jingsong Zhang, Channing J Paller, Joel Picus, Zachery R Reichert, Russell Zelig Szmulewitz, Scott T Tagawa, Timothy M Kuzel, Latifa A Bazzi, Stephanie Daignault-Newton, Young E Whang, Robert Dreicer, Ryan D Stephenson, Matthew B Rettig, Daniel Shevrin, Travis A Gerke, Arul M Chinnaiyan, Emmanuel S Antonarakis
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer research communications 4 (5) (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. Cancer research communications 4 (8) (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Julie N Graff, Christopher J Hoimes, Winald R Gerritsen, Ulka N Vaishampayan, Tony Elliott, Clara Hwang, Albert J Ten Tije, Aurelius Omlin, Raymond S McDermott, Yves Fradet, Scott T Tagawa, Deepak Kilari, Cristiano Ferrario, Hiroji Uemura, Robert J Jones, Satoshi Fukasawa, Avivit Peer, Cuizhen Niu, Christian H Poehlein, Ping Qiu, Leah Suttner, Ronald de Wit, Charles Schloss, Johann S de Bono, Emmanuel S Antonarakis
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study. Prostate cancer and prostatic diseases (2024)
Matthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, Nivedita Chowdhury, Aditya Pratapa, David Henry Aggen, Christopher D Gaffney, Karen A Autio, Renu K Virk, Angelo M DeMarzo, Emmanuel S Antonarakis, Howard I Scher, Charles G Drake, Dana E Rathkopf
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. Cancer research communications 4 (8) (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase 2 Trial. Cancer research communications (2024)
Channing J Paller, Hanna Tukachinsky, Alexandra Maertens, Brennan Decker, Julian R Sampson, Jeremy P Cheadle, Emmanuel S Antonarakis
Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors. JCO precision oncology 8 (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley Ross, Catherine Marshall, Kelly Stratton, Adanma Ayanambakkam, Michael Cookson, Rana R McKay, Alan H Bryce, Marina Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target across Human Malignancies. Cancer research communications (2024)
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patniak, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate cancer and prostatic diseases (2024)
Emmanuel S Antonarakis, Nicole Zhang, Jayati Saha, Liina Nevalaita, Tarja Ikonen, L Jill Tsai, Chris Garratt, Karim Fizazi
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Charles B Nguyen, Melissa A Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y Feng, Emmanuel S Antonarakis, Rana R McKay, Russell K Pachynski, Jingsong Zhang, Zachery R Reichert, Phillip L Palmbos, Megan E V Caram, Ulka N Vaishampayan, Elisabeth I Heath, Alexander C Hopkins, Marcin P Cieslik, Yi-Mi Wu, Dan R Robinson, Veerabhadran Baladandayuthapani, Arul M Chinnaiyan, Ajjai Shivaram Alva
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patniak, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate cancer and prostatic diseases (2024)
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patniak, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate cancer and prostatic diseases (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Mayuko Kanayama, Hua-Ling Tsai, Hao Wang, Emmanuel S Antonarakis, Samuel R Denmeade, Jun Luo
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial. Prostate cancer and prostatic diseases (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer research communications 4 (5) (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley Ross, Catherine Marshall, Kelly Stratton, Adanma Ayanambakkam, Michael Cookson, Rana R McKay, Alan H Bryce, Marina Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Channing J Paller, Hanna Tukachinsky, Alexandra Maertens, Brennan Decker, Julian R Sampson, Jeremy P Cheadle, Emmanuel S Antonarakis
Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors. JCO precision oncology 8 (2024)
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patniak, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate cancer and prostatic diseases (2024)
Channing J Paller, Hanna Tukachinsky, Alexandra Maertens, Brennan Decker, Julian R Sampson, Jeremy P Cheadle, Emmanuel S Antonarakis
Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors. JCO precision oncology 8 (2024)
Sharon H Choi, Elizabeth Pan, Andrew Elliott, Himisha Beltran, Justine Panian, Christina A M Jamieson, Aditya Bagrodia, Brent S Rose, Daniel Herchenhorn, Elisabeth I Heath, Chadi Nabhan, Emmanuel S Antonarakis, Rana R McKay
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer. Molecular cancer research : MCR (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. Cancer research communications 4 (8) (2024)
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patniak, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate cancer and prostatic diseases (2024)
Emmanuel S Antonarakis, Nicole Zhang, Jayati Saha, Liina Nevalaita, Tarja Ikonen, L Jill Tsai, Chris Garratt, Karim Fizazi
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Santosh Gupta, Susan Halabi, Qian Yang, Akash Roy, Alisa Tubbs, Yamini Gore, Daniel J George, David M Nanus, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Richard Wenstrup, Andrew J Armstrong
PSMA-positive circulating tumor cell detection and outcomes with abiraterone or enzalutamide treatment in men with metastatic castrate resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sanaz Nourmohammadi Abadchi, Laura A Sena, Emmanuel S Antonarakis, Colin C Pritchard, James R Eshleman, Eric Quentin Konnick, Stephen J Salipante, Eugene Shenderov, Tamara L Lotan
MLH1 Loss in Primary Prostate Cancer. JCO precision oncology 7 (2023)
Eugene Shenderov, Angelo M DeMarzo, Tamara L Lotan, Hao Wang, Sin Chan, Su Jin Lim, Hongkai Ji, Mohamad E Allaf, Carolyn Chapman, Paul A Moore, Francine Chen, Kristina Sorg, Andrew M White, Sarah E Church, Briana Hudson, Paul A Fields, Shaohui Hu, Samuel R Denmeade, Kenneth J Pienta, Christian P Pavlovich, Ashley E Ross, Charles G Drake, Drew M Pardoll, Emmanuel S Antonarakis
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial. Nature medicine (2023)
Ali T Arafa, Aditya Jain, Pavel Skrobanek, Brad Humphrey, Jerry W Froelich, Emmanuel S Antonarakis
Impact of piflufolastat F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states: A retrospective review. The Prostate (2023)
Adel Mandl, Mark C Markowski, Michael A Carducci, Emmanuel S Antonarakis
Role of Bromodomain and Extraterminal (BET) Proteins in Prostate Cancer. Expert opinion on investigational drugs (2023)
Michael J Morris, Glenn Heller, David W Hillman, Olivia Bobek, Charles Ryan, Emmanuel S Antonarakis, Alan H Bryce, Olwen Hahn, Himisha Beltran, Andrew J Armstrong, Lawrence Schwartz, Lionel D Lewis, Jan H Beumer, Brooke Langevin, Eric C McGary, Paul T Mehan, Amir Goldkorn, Bruce J Roth, Han Xiao, Colleen Watt, Mary-Ellen Taplin, Susan Halabi, Eric J Small
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Angela Y Jia, Ana P Kiess, Qiubai Li, Emmanuel S Antonarakis
Radiotheranostics in advanced prostate cancer: Current and future directions. Prostate cancer and prostatic diseases (2023)
Sydney A Caputo, Madeline Hawkins, Ellen B Jaeger, William Fleming, Crystal Casado, Charlotte Manogue, Minqi Huang, Alex Lieberman, Malcolm Light, Isabelle P Sussman, Patrick Miller, Pedro C Barata, Brian E Lewis, Jodi Lyn Layton, Elisa M Ledet, Emmanuel S Antonarakis, A Oliver Sartor
Clinical and Molecular Determinants of PSA Response to Bipolar Androgen Therapy in Prostate Cancer. The Prostate (2023)
Justin H Hwang, Xiaolei Shi, Andrew Elliott, Taylor E Arnoff, Julie E McGrath, Joanne Xiu, Phillip Walker, Hannah E Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, Allison Makovec, Atef Ali, Rami M Shaker, Eamon Toye, Rachel Passow, John R Lozada, Jinhua Wang, Emil Lou, Kent W Mouw, Benedito Arruda Carneiro, Elisabeth I Heath, Rana R McKay, Wolfgang Michael Korn, Chadi Nabhan, Charles J Ryan, Emmanuel S Antonarakis
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ludimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, Benedito A Carneiro, Don S Dizon, Kartik Angara, Tyler Mattox, Sharon Wu, Joanne Xiu, Phillip Walker, Matthew J Oberley, Chadi Nabhan, Haojie Huang, Emmanuel S Antonarakis
Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers. JCO precision oncology 7 (2023)
Emmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, Lawrence Ivan Karsh, David I Quinn, Jason M Hafron, Helen M Wilfehrt, Matthew Harmon, Nadeem A Sheikh, Neal D Shore, Daniel P Petrylak
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jay A Moore, Kuei-Ting Chen, Russell W Madison, Justin Y Newberg, Zoe Fleischmann, Shuoguo Wang, Radwa Sharaf, Karthikeyan Murugesan, Bernard J Fendler, Jason Hughes, Alexa B Schrock, Priti S Hegde, Geoffrey R Oxnard, David Fabrizio, Garrett M Frampton, Emmanuel S Antonarakis, Ethan S Sokol, Dexter X Jin
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response. JCO precision oncology 7 (2023)
Alexander Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, Smruthy S Sivakumar, Alexa B Schrock, Hannah E Bergom, Hedyeh Ebrahimi, Sumanta Kumar Pal, Tanya Barauskas Dorff, Archana M Agarwal, Brandon A Mahal, Geoffrey R Oxnard, Justin H Hwang, Emmanuel S Antonarakis
Unique spectrum of activating BRAF alterations in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ali T Arafa, Leah R Blader, Karan Ramakrishna, Jeff Engle, Charles J Ryan, Nicholas A Zorko, Gautam Jha, Emmanuel S Antonarakis
Clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retrospective case-control study. The Prostate (2023)
Amado J Zurita, Ryon P Graf, Guillermo Villacampa, Kira Raskina, Ethan S Sokol, Dexter Jin, Emmanuel S Antonarakis, Gerald Li, Richard S P Huang, Irene Casanova-Salas, Ana Vivancos, Joan Carles, Jeffery S Ross, Alexa B Schrock, Geoffrey R Oxnard, Joaquin Mateo
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies. JCO precision oncology 6 (2022)
Zoila A Lopez-Bujanda, Aleksandar Z Obradovic, Thomas R Nirschl, Laura Crowley, Rodney Macedo, Alexandros Papachristodoulou, Timothy O'Donnell, Uri Laserson, Jelani C Zarif, Ran Reshef, Tiezheng Yuan, Mithil K Soni, Emmanuel S Antonarakis, Michael C Haffner, H Benjamin Larman, Michael M Shen, Pawel Muranski, Charles G Drake
TGM4: an immunogenic prostate-restricted antigen. Journal for immunotherapy of cancer 9 (6) (2022)
Samuel R Denmeade, Emmanuel S Antonarakis, Mark C Markowski
Bipolar androgen therapy (BAT): A patient's guide. The Prostate 82 (7) (2022)
Emmanuel S Antonarakis, Marni Tierno, Virginia A Fisher, Hanna Tukachinsky, Sonja Alexander, Omar Hamdani, Matthew C Hiemenz, Richard S P Huang, Geoffrey R Oxnard, Ryon P Graf
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer. The Prostate 82 (7) (2022)
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y Song, Arthur Y Hung, Jason W D Hearn, Steven Miller, James A Proudfoot, Matthew P Deek, Ryan Phillips, Tamara Lotan, Channing J Paller, Catherine Handy Marshall, Mark C Markowski, Shirl Dipasquale, Samuel R Denmeade, Michael Carducci, Mario A Eisenberger, Theodore L DeWeese, Matthew Orton, Curtiland Deville, Elai Davicioni, Stanley L Liauw, Elisabeth I Heath, Stephen Greco, Neil B Desai, Daniel E Spratt, Felix Y Feng, Hao Wang, Tomasz M Beer, Emmanuel S Antonarakis
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ethan S Sokol, Dexter X Jin, Alexander D Fine, Sally E Trabucco, Sophia Maund, Garrett M Frampton, Luciana L Molinero, Emmanuel S Antonarakis
PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers. JCO precision oncology 6 (2022)
Christopher T Su, Emily Nizialek, Jacob E Berchuck, Panagiotis J Vlachostergios, Ryan Ashkar, Alexandra O Sokolova, Pedro C Barata, Rahul R Aggarwal, Rana R McKay, Neeraj Agarwal, Heather M McClure, Nellie N Nafissi, Alan H Bryce, A Oliver Sartor, Nicolas Sayegh, Heather H Cheng, Nabil Adra, Cora N Sternberg, Mary-Ellen Taplin, Marcin Cieslik, Ajjai S Alva, Emmanuel S Antonarakis
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer. The Prostate (2022)
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, Virginia A Fisher, Hanna Tukachinsky, Alexa B Schrock, Gerald Li, Jeffery S Ross, Nicolas Sayegh, Nishita Tripathi, Vinay M Thomas, Geoffrey R Oxnard, Emmanuel S Antonarakis, Archana M Agarwal
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Catherine Handy Marshall, Lukasz P Gondek, Jun Luo, Emmanuel S Antonarakis
Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies. Cancer research 82 (22) (2022)
Matthew P Deek, Kim Van der Eecken, Philip Sutera, Rebecca A Deek, Valérie Fonteyne, Adrianna A Mendes, Karel Decaestecker, Ana Ponce Kiess, Nicolaas Lumen, Ryan Phillips, Aurélie De Bruycker, Mark Mishra, Zaker Rana, Jason K Molitoris, Bieke Lambert, Louke Delrue, Hailun Wang, Kathryn Lowe, Sofie L J Verbeke, Jo Van Dorpe, Renée Bultijnck, Geert Villeirs, Kathia De Man, Filip Ameye, Daniel Y Song, Theodore DeWeese, Channing J Paller, Felix Y Feng, Alexander W Wyatt, Kenneth J Pienta, Maximillian Diehn, Soren M Bentzen, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Emmanuel S Antonarakis, Tamara L Lotan, Alejandro Berlin, Shankar Siva, Piet Ost, Phuoc T Tran
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Alexandra O Sokolova, Catherine H Marshall, Rebeca Lozano, Roman Gulati, Elisa M Ledet, Navonil De Sarkar, Petros Grivas, Celestia S Higano, Bruce Montgomery, Peter S Nelson, David Olmos, Vadim Sokolov, Michael Thomas Schweizer, Todd A Yezefski, Evan Y Yu, Channing J Paller, A Oliver Sartor, Elena Castro, Emmanuel S Antonarakis, Heather H Cheng
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. The Prostate 81 (16) (2021)
Elisa M Ledet, Earle F Burgess, Alexandra O Sokolova, Ellen B Jaeger, Whitley Hatton, Marcus Moses, Patrick Miller, Patrick Cotogno, Jodi Layton, Pedro Barata, Brian E Lewis, Mari Nakazawa, Jason Zhu, Beth Dellinger, Sara Elrefai, Nellie N Nafissi, Jan B Egan, Neal Shore, Rana R McKay, Alan H Bryce, Heather H Cheng, Emmanuel S Antonarakis, A Oliver Sartor
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. The Prostate 81 (7) (2021)
Samuel R Denmeade, Hao Wang, Archana M Agarwal, David C Smith, Michael Thomas Schweizer, Mark N Stein, Vasileios Assikis, Przemyslaw W Twardowski, Thomas W Flaig, Russell Z Szmulewitz, Jeffrey M Holzbeierlein, Ralph J Hauke, Guru P Sonpavde, Jorge A Garcia, Arif Hussain, A Oliver Sartor, Shifeng S Mao, Harry Cao, Wei Fu, Ting Wang, Rehab Abdallah, Su Jin Lim, Vanessa Cilento, Channing J Paller, Michael A Carducci, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Mayuko Kanayama, Changxue Lu, Jun Luo, Emmanuel S Antonarakis
AR Splicing Variants and Resistance to AR Targeting Agents. Cancers 13 (11) (2021)
Benjamin L Maughan, Emmanuel S Antonarakis
Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer. Expert opinion on pharmacotherapy 22 (12) (2021)
Mari Nakazawa, Mike Fang, Catherine Handy Marshall, Tamara L Lotan, Pedro Isaacsson Velho, Emmanuel S Antonarakis
Clinical and genomic features of SPOP-mutant prostate cancer. The Prostate (2021)
Emily Nizialek, Su Jin Lim, Hao Wang, Pedro Isaacsson Velho, Srinivasan Yegnasubramanian, Emmanuel S Antonarakis
Genomic profiles and clinical outcomes in primary versus secondary metastatic hormone-sensitive prostate cancer. The Prostate 81 (9) (2021)
Tamara L Lotan, Harsimar B Kaur, Daniela C Salles, Sanjana Murali, Edward M Schaeffer, Jerry S Lanchbury, William B Isaacs, Robert Brown, Andrea L Richardson, Olivier Cussenot, Geraldine Cancel-Tassin, Kirsten M Timms, Emmanuel S Antonarakis
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (6) (2021)
Eugene Shenderov, Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan, Donna Dowling, Rana Harb, Joseph Schonhoft, Adam Jendrisak, Michael A Carducci, Mario A Eisenberger, James R Eshleman, Jun Luo, Charles G Drake, Drew M Pardoll, Emmanuel S Antonarakis
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial. The Prostate 81 (6) (2021)
Laura A Sena, Samuel R Denmeade, Emmanuel S Antonarakis
Targeting the spectrum of immune checkpoints in prostate cancer. Expert review of clinical pharmacology 14 (10) (2021)
Neal D Shore, Emmanuel S Antonarakis, Michael S Cookson, E David Crawford, Alicia K Morgans, David M Albala, Jason Hafron, Richard G Harris, Daniel Saltzstein, Gordon A Brown, Jonathan Henderson, Benjamin Lowentritt, Jeffrey M Spier, Raoul Concepcion
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines. The Prostate 80 (6) (2020)
Emmanuel S Antonarakis
Olaparib for DNA repair-deficient prostate cancer - one for all, or all for one? Nature reviews. Clinical oncology 17 (8) (2020)
Mark C Markowski, Eugene Shenderov, Mario A Eisenberger, Sushant Kachhap, Drew M Pardoll, Samuel R Denmeade, Emmanuel S Antonarakis
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer. The Prostate 80 (5) (2020)
Mark C Markowski, Emmanuel S Antonarakis
PARP inhibitors in prostate cancer: time to narrow patient selection? Expert review of anticancer therapy 20 (7) (2020)
Mario A Eisenberger, Emmanuel S Antonarakis
Hormonal Therapy or Chemotherapy for Metastatic Prostate Cancer - Playing the Right CARD. The New England journal of medicine 381 (26) (2020)
Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302. The Prostate 79 (8) (2020)
Andrew J Armstrong, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel Costin Danila, Patrick Healy, Monika Anand, William R Berry, Tian Zhang, Michael R Harrison, Changxue Lu, Yan Chen, Giuseppe Galletti, Joseph D Schonhoft, Howard I Scher, Richard Wenstrup, Scott T Tagawa, Emmanuel S Antonarakis, Daniel J George, Susan Halabi
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 4 (2020)
Emmanuel S Antonarakis
α-Particle-Emitter Radiopharmaceutical Therapy: Resistance Is Futile. Cancer research 79 (21) (2020)
Benjamin L Maughan, Emmanuel S Antonarakis
Does sequencing order of antiandrogens in prostate cancer matter? Nature reviews. Urology 17 (4) (2020)
Eugene Shenderov, Pedro Isaacsson Velho, Anas H Awan, Hao Wang, Nooshin Mirkheshti, Tamara L Lotan, Michael A Carducci, Drew M Pardoll, Mario A Eisenberger, Emmanuel S Antonarakis
Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype. The Prostate 79 (13) (2019)
Channing J Paller, Danilo Piana, James R Eshleman, Stacy Riel, Samuel R Denmeade, Pedro Isaacsson Velho, Steven P Rowe, Martin G Pomper, Emmanuel S Antonarakis, Jun Luo, Mario A Eisenberger
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer. The Prostate 79 (14) (2019)
Elisa M Ledet, Emmanuel S Antonarakis, William B Isaacs, Tamara L Lotan, Colin Pritchard, A Oliver Sartor
Germline BLM mutations and metastatic prostate cancer. The Prostate 80 (2) (2019)
Alireza Karimian, Nathan T Ji, Hong Song, Emmanuel S Antonarakis
Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy. Cancer research 80 (4) (2019)
Pedro Isaacsson Velho, John L Silberstein, Mark C Markowski, Jun Luo, Tamara L Lotan, William B Isaacs, Emmanuel S Antonarakis
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. The Prostate 78 (5) (2018)
Emmanuel S Antonarakis
AR Signaling in Human Malignancies: Prostate Cancer and Beyond. Cancers 10 (1) (2018)
Emmanuel S Antonarakis
Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer. The New England journal of medicine 379 (11) (2018)
Mike Fang, Mary Nakazawa, Emmanuel S Antonarakis, Chun Li
Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis. Prostate cancer 2017 (2017)

Emmanuel S Antonarakis.css-eqlu8i{font-size:small;padding-left:4px;} (George Sgouros, Emmanuel Antonarakis)

Publication Activity (10 Years)

Top Topics

Top Venues

Emmanuel S Antonarakis (George Sgouros, Emmanuel Antonarakis)